Q4 adj. EBITDA USD 10.6m (ARCe USD 13m, consensus USD 11.5)HHI adj. EBITDA USD 14.1m (ARCe USD 13.5m, consensus USD 13.3)Est. Superba sales 240 tonnes (ARCe 242t)Net debt USD 157m (ARCe 163m)Company has engaged advisers to support HHI transaction in 2026Stock to rise on strong Q1 guidance and sale of HHI is getting closer
12 Feb 2026
Arctic FLASH: Aker BioMarine - Strong HHI development
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Arctic FLASH: Aker BioMarine - Strong HHI development
Aker BioMarine ASA (AKBM:OSL) | 0 0 0.0%
- Published:
12 Feb 2026 -
Author:
Kristoffer Haugland | Christian Olsen Nordby -
Pages:
13 -
Q4 adj. EBITDA USD 10.6m (ARCe USD 13m, consensus USD 11.5)HHI adj. EBITDA USD 14.1m (ARCe USD 13.5m, consensus USD 13.3)Est. Superba sales 240 tonnes (ARCe 242t)Net debt USD 157m (ARCe 163m)Company has engaged advisers to support HHI transaction in 2026Stock to rise on strong Q1 guidance and sale of HHI is getting closer